1. Introduction
Biotechnology has transformed the procedure of developing medications through identifying, creating, and manufacturing medications (1). The collective application of biological processes and technological innovations have provided considerable scientific advances, remarkably in parts associated with explicit treatments, personalised medicine, and genomic alteration (2).
2. Biotech Tools and Techniques in Medicines Development
2.1 Genetic Engineering.
CRISPR editing of genes is an innovation in molecular biology that enables the alteration of an organism's genetic makeup through the use of genetic engineering. The technique is based on a simplified version of the bacterial CRISPR-Cas9 antiviral protection enzyme. CRISPR/Cas9 is a genomic engineering procedure that permits accurate DNA adjustments, that lead to the development and reach of genetically engineered medicines (3).
2.2 Monoclonal Antibodies.
Monoclonal antibodies are formed by matching immune cells, which are copies of only a parent cell. They are employed to treat a variation of conditions, exclusively cancer and auto-immune illnesses (4).
2.3 Recombinant DNA Technology.
Recombinant DNA manufacturing empowers the integration of new DNA in an organism's genome, allowing the engineering of therapeutic proteins (5).
2.4 Protein Engineering.
Protein manufacturing is the procedure of designing and structuring new proteins, also, altering existing ones, to improve therapeutic properties (6).
3. Drug Discovery and Development Process
3.1 Target Identification and Validation
Biotechnology techniques are utilised to establish and confirm biological goals to develop medications, such as proteins or genes that perform a role in illness processes (7).
3.2 High-Throughput Screening
High-throughput screening (HTS) is a technique that comprises the examination of a huge amount of composites to find the ones that exhibit a specific intended conclusion on a biological target (7).
3.3 Preclinical and Clinical Trials
Biotechnology helps in the development of preclinical models and designs for clinical trials, enhancing the assessment of the safety and effectiveness of pharmaceuticals (8).
4. Innovations in Biotechnology for Drug Development
4.1 Gene Therapy
Gene therapy is the process of introducing or modifying genetic material in a patient's cells to treat or prevent disease (9).
4.2 Cell Therapy
Cell therapy involves the transfer of intact cells into a patient's body to treat or control a disease (10).
4.3 Personalised Medicine
Personalised medicine employs environmental, genetic, and lifestyle data to customise treatments for specific patients (11).
5. Regulatory and ethical considerations.
5.1 Regulatory Framework
Regulatory Framework The government bodies regulate the licensing and regulation of biotech medications (12).
5.2 Ethical issues
Ethical concerns in biotechnology include editing genes, confidentiality, and equal distribution of emerging therapies (13).
6. Future Trends and Challenges.
6.1 Integration with Artificial Intelligence
Artificial intelligence (AI) has emerged as more prevalent in drug discovery, providing new methods for analysing data and predicting medication interactions (14).
6.2 Managing Global Health Challenges
Biotechnology is critical for addressing global health issues like pandemics, resistance to antibiotics, and persistent illnesses (15).
7. Conclusion.
Biotechnology plays an important part in developing medicines, from the initial stages of research to marketable products. Emerging technologies, regulatory frameworks, and worldwide health needs are probably to shape biotechnology's future in developing medicines (16).
References
1. Jacobson, M., & Jacobson, E. (2020). Introduction to Biotechnology: How Biotech is Changing Medicine. Springer.
2. Harvard Business Review. (2018). “How Biotechnology is Transforming Drug Development.” Harvard Business Review.
3. Doudna, J. A., & Charpentier, E. (2014). “The New Frontier of Genome Editing with CRISPR-Cas9.” Science, 346(6213), 1258096. Link.
4. Kohler, G., & Milstein, C. (1975). “Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity.” Nature, 256, 495-497. Link.
4. Sambrook, J., & Russell, D. W. (2001). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press.
5, Noren, C. J., & Anthony-Cahill, S. J. (1993). “Protein Engineering: Improving Proteins and Processes.” Annual Review of Biochemistry, 62, 171-209. Link.
6. Sridhar, R., & Schürer, S. C. (2018). “Target Identification and Validation in Drug Discovery.” Drug Discovery Today, 23(6), 1235-1245. Link.
7. Sittampalam, G. S., et al. (2015). “High-Throughput Screening Assays and Drug Discovery: A Review.” Current Opinion in Chemical Biology, 24, 18-25.
8. Yamashita, S., & Kuroda, Y. (2016). “Biotechnology in Preclinical and Clinical Trials.” Journal of Clinical Pharmacology, 56(1), 27-38.
9. Hosseini, S. M., & Shahnazari, N. (2020). “Gene Therapy: An Overview of Current Technologies.” Gene Therapy, 27(8), 391-399. Link.
10. Stewart, R. J., & Hsu, P. Y. (2021). “Advances in Cell Therapy and Its Role in Drug Development.” Cell Stem Cell, 28(4), 530-544. Link.
11. Collins, F. S., & Varmus, H. (2015). “A New Era in Medicine: Personalized Health Care.” Science, 349(6255), 500-501. Link.
12. Landy, A. C., & Meyer, L. H. (2019). “Regulatory Challenges in Biotechnology Drug Development.” Regulatory Affairs Journal, 18(2), 112-121. Link.
13. Jasanoff, S. (2006). Biotechnology and Society: An Introduction. Routledge.
14. Baker, M. (2021). “AI in Drug Discovery: The Future of Pharmaceutical Research.” Nature Reviews Drug Discovery, 20, 160-161. Link.
15. Zhang, X., & Li, Z. (2020). “Biotechnology in Addressing Global Health Issues: A Review.” Global Health, 16(1), 45. Link.
16. Anderson, D. W. (2019). “The Future of Biotechnology in Drug Development: Trends and Predictions.” Pharmaceutical Research, 36(5), 1046-1054. Link.